BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9457825)

  • 1. Place of low-dose total body irradiation in the treatment of localized follicular non-Hodgkin's lymphoma: results of a pilot study.
    Richaud PM; Soubeyran P; Eghbali H; Chacon B; Marit G; Broustet A; Hoerni B
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):387-90. PubMed ID: 9457825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage extended-field irradiation in follicular non-Hodgkin's lymphoma after failure of chemotherapy.
    Mahé Ma; Bourdin S; Le Pourhiet-Le Mevel A; Moreau P; Campion L; Hamidou M; Milpied N; Moreau A; Gaillard F; Harousseau JL; Cuillière JC
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):735-8. PubMed ID: 10837958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended field and total central lymphatic radiotherapy in the treatment of early stage lymph node centroblastic-centrocytic lymphomas: results of a prospective multicenter study. Study Group NHL-frühe Stadien.
    Stuschke M; Hoederath A; Sack H; Pötter R; Müller RP; Schulz U; Karstens J; Makoski HB
    Cancer; 1997 Dec; 80(12):2273-84. PubMed ID: 9404705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of total body irradiation in chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphomas.
    Roncadin M; Arcicasa M; Bortolus R; Trovó MG; Carbone A; Tirelli U; De Paoli A; Franchin G; Grigoletto E
    Cancer Invest; 1991; 9(4):403-7. PubMed ID: 1884246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience.
    Tezcan H; Vose JM; Bast M; Bierman PJ; Kessinger A; Armitage JO
    Leuk Lymphoma; 1999 Jul; 34(3-4):273-85. PubMed ID: 10439364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results with radiotherapy for Stage I-II follicular lymphomas.
    Wilder RB; Jones D; Tucker SL; Fuller LM; Ha CS; McLaughlin P; Hess MA; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1219-27. PubMed ID: 11728680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total body irradiation and prednimustine in chronic lymphocytic leukemia and low grade non-Hodgkin's lymphomas. A 9-year experience at a single institution.
    Roncadin M; Arcicasa M; Zagonel V; Bortolus R; Valeri P; Pinto A; De Paoli A; Franchin G; Carbone A; Trovò MG
    Cancer; 1994 Aug; 74(3):978-84. PubMed ID: 8039128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centroblastic-centrocytic non-Hodgkin's lymphoma stage I-III: patterns of failure following radiotherapy.
    Frank C; Zierhut D; Schulz-Ertner D; Wannenmacher M
    Strahlenther Onkol; 2001 Nov; 177(11):597-603. PubMed ID: 11757182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized low-dose radiotherapy for follicular lymphoma: history, clinical results, mechanisms of action, and future outlooks.
    Ganem G; Cartron G; Girinsky T; Haas RL; Cosset JM; Solal-Celigny P
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):975-82. PubMed ID: 20970029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy for stage I-III nodal low-grade non-Hodgkin's lymphoma.
    Ott OJ; Rödel C; Gramatzki M; Niedobitek G; Sauer R; Grabenbauer GG
    Strahlenther Onkol; 2003 Oct; 179(10):694-701. PubMed ID: 14566478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy of relapse-refractory follicular lymphoma.
    Grignano É; Deau-Fischer B; Loganadane G; Breton M; Burroni B; Bouscary D; Kirova YM
    Cancer Radiother; 2018 Apr; 22(2):126-130. PubMed ID: 29477304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie.
    Raemaekers J; Burgers M; Henry-Amar M; Pinna A; Mandard A; Monfardini S; Hagenbeek A; Breed W; Carde P; Vovk M; van Hoof A; Thomas J; Noordijk E
    Ann Oncol; 1997; 8 Suppl 1():111-4. PubMed ID: 9187443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study on the use of the ProMACE-CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi.
    Baldini L; Guffanti A; Gobbi P; Colombi M; Federico M; Avanzini P; Cavanna L; Pieresca C; Silingardi V; Maiolo AT
    Cancer; 1997 Mar; 79(6):1234-40. PubMed ID: 9070503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas.
    Saleh K; Michot JM; Schernberg A; Lazarovici J; Chahine C; Danu A; Khalife-Saleh N; Rossignol J; Ghez D; Martin V; Mazeron R; Fermé C; Boros A; Ribrag V; Girinsky T
    Cancer Med; 2020 Jun; 9(11):3725-3732. PubMed ID: 32249547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose radiotherapy in indolent lymphomas, enough is enough.
    Haas RL
    Hematol Oncol; 2009 Jun; 27(2):71-81. PubMed ID: 19266491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).
    Zinzani PL; Tani M; Pulsoni A; Gobbi M; Perotti A; De Luca S; Fabbri A; Zaccaria A; Voso MT; Fattori P; Guardigni L; Ronconi S; Cabras MG; Rigacci L; De Renzo A; Marchi E; Stefoni V; Fina M; Pellegrini C; Musuraca G; Derenzini E; Pileri S; Fanti S; Piccaluga PP; Baccarani M
    Lancet Oncol; 2008 Apr; 9(4):352-8. PubMed ID: 18342572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study.
    Ha CS; Kong JS; Tucker SL; McLaughlin P; Wilder RB; Hess MA; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):316-20. PubMed ID: 12957240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.
    Mac Manus MP; Hoppe RT
    J Clin Oncol; 1996 Apr; 14(4):1282-90. PubMed ID: 8648385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radiotherapy of follicle center lymphoma. Results of a German multicenter and prospective study. Members of the Study Group "NHL-early stages"].
    Sack H; Hoederath A; Stuschke M; Bohndorf W; Makoski HB; Müller RP; Pötter R
    Strahlenther Onkol; 1998 Apr; 174(4):178-85; discussion 186. PubMed ID: 9581177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.